Afatinib Recruiting Phase 1 / 2 Trials for Neuroectodermal Tumors / Rhabdomyosarcomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs